Chemical Synthesis and Enzymatic Incorporation of Artificial Nucleotides
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
CHAPTER 1 OLIGONUCLEOTIDES Part 2 – Noncanonical
CHAPTER 1 OLIGONUCLEOTIDES Part 2 – noncanonical nucleobases Canonical nucleobase pairing Nucleobase modifications for biosynthetic Alternative base pairs – synthetic biology Cyanophage S-2L uses diaminopurine instead of adenine (3 H-bonds!) DAP – one tautomer forms a base pair with guanine iso-C/iso-G - specificity (the enol tautomer of iso-G, stabilized by aromatization, complementary to thymine) - the 2-amino group of iso-C hydrolyses easily to uracil Natural and non-natural base pairs that function in polymerase reactions AEGIS – Artificially Expanded Genetic Information System Watson–Crick pairing rules: (a) size complementarity - large purines pair with small pyrimidines (b) hydrogen-bonding complementarity (hydrogen-bond acceptors, A, pair with hydrogen-bond donors, D). isoC isoG Rearranging donor and acceptor groups on the nucleobases, while not changing the geometry of the Watson–Crick pair, creates an artificially expanded genetic information system (AEGIS). AEGIS components add information density to DNA strands built from them. S. Benner et al., Beilstein J. Org. Chem. 2014, 10, 2348–2360. doi:10.3762/bjoc.10.245 Artificial Gene Synthesis Artificial gene synthesis (DNA printing) - method in synthetic biology to create artificial genes in the laboratory: - currently based on solid-phase DNA synthesis, - the user does not have to begin with preexisting DNA sequences. - Therefore, it is possible to make a completely synthetic double-stranded DNA molecule with no apparent limits on either nucleotide sequence or size. Applications: • recombinant DNA technology including heterologous gene expression, vaccine development, gene therapy and molecular engineering. • The synthesis of nucleic acid sequences can be more economical than classical cloning and mutagenesis procedures • the ability to safely obtain genes for vaccine research without the need to grow the full pathogens. -
Future of the Genetic Code
life Review Future of the Genetic Code Hong Xue and J. Tze-Fei Wong * Division of Life Science and Applied Genomics Center, Hong Kong University of Science & Technology, Clear Water Bay, Hong Kong, China; [email protected] * Correspondence: [email protected]; Tel.: +852-2358-7288; Fax: +852-2358-1552 Academic Editor: Koji Tamura Received: 6 January 2017; Accepted: 23 February 2017; Published: 28 February 2017 Abstract: The methods for establishing synthetic lifeforms with rewritten genetic codes comprising non-canonical amino acids (NCAA) in addition to canonical amino acids (CAA) include proteome-wide replacement of CAA, insertion through suppression of nonsense codon, and insertion via the pyrrolysine and selenocysteine pathways. Proteome-wide reassignments of nonsense codons and sense codons are also under development. These methods enable the application of NCAAs to enrich both fundamental and applied aspects of protein chemistry and biology. Sense codon reassignment to NCAA could incur problems arising from the usage of anticodons as identity elements on tRNA, and possible misreading of NNY codons by UNN anticodons. Evidence suggests that the problem of anticodon as identity elements can be diminished or resolved through removal from the tRNA of all identity elements besides the anticodons, and the problem of misreading of NNY codons by UNN anticodon can be resolved by the retirement of both the UNN anticodon and its complementary NNA codon from the proteome in the event that a restrictive post-transcriptional modification of the UNN anticodon by host enzymes to prevent the misreading cannot be obtained. Keywords: synthetic life; non-canonical amino acid; rewritten genetic code; restrictive post-transcriptional modification; anticodon identity element 1. -
Expansion of the Genetic Code Via Expansion of the Genetic Alphabet
Available online at www.sciencedirect.com ScienceDirect Expansion of the genetic code via expansion of the genetic alphabet 1 1 1 Vivian T Dien , Sydney E Morris , Rebekah J Karadeema and Floyd E Romesberg Current methods to expand the genetic code enable site- proteins as therapeutics [1], these limitations are prob- specific incorporation of non-canonical amino acids (ncAAs) lematic, as the physiochemical diversity of the natural into proteins in eukaryotic and prokaryotic cells. However, amino acids is dramatically restricted compared to that of current methods are limited by the number of codons possible, the small molecule drugs designed by chemists. In prin- their orthogonality, and possibly their effects on protein ciple, it should be possible to circumvent these limita- synthesis and folding. An alternative approach relies on tions by expanding the genetic code to include additional, unnatural base pairs to create a virtually unlimited number of non-canonical amino acids (ncAAs) with desired physio- genuinely new codons that are efficiently translated and highly chemical properties. orthogonal because they direct ncAA incorporation using forces other than the complementary hydrogen bonds Almost 20 years ago, Peter Schultz increased the diversity employed by their natural counterparts. This review outlines available to living organisms by expanding the genetic progress and achievements made towards developing a code using the amber stop codon (UAG) to encode ncAAs functional unnatural base pair and its use to generate semi- in Escherichia coli [2 ,3 ]. This landmark accomplish- synthetic organisms with an expanded genetic alphabet that ment was achieved using a tRNA–amino acid tRNA serves as the basis of an expanded genetic code. -
Synthetic Biology
Synthetic Biology © NATALIMIS / Fotolia 2nd Interim report of the German Central Committee on Biological Safety June 2018 Az. 46012 Contents Summary ............................................................................................... 3 Zusammenfassung ............................................................................... 5 1 Introduction ..................................................................................... 7 1.1 What is Synthetic Biology ........................................................................................ 7 1.2 Aim of the report .....................................................................................................10 2 Research approaches in Synthetic Biology ................................ 11 2.1 Synthesis of genes and genomes ...........................................................................12 2.2 Design of genetic signalling circuits ........................................................................17 2.3 Metabolic engineering ............................................................................................22 2.4 Minimal cells: Genome reduction and production of protocells ...............................25 2.5 Xenobiology ...........................................................................................................30 3 Research trends and social discussion ...................................... 34 4 References .................................................................................... 35 2 Summary Summary In this report, -
In Vivo Replication of Semi-Synthetic
RESEARCH HIGHLIGHTS Nature Reviews Genetics | AOP, published online 20 May 2014; doi:10.1038/nrg3759 NPG SYNTHETIC BIOLOGY In vivo replication of semi-synthetic DNA In a new groundbreaking study, scientists from The Scripps Research Institute have engineered a semi-synthetic organism that contains an unnatural base pair (UBP; d5SICS∙dNaM) and that can reproduce normally. This is the first time that DNA containing a synthetic base pair has been replicated successfully in vivo, and this work has potential implications for information storage in DNA and the re-engineering of cells for a range of applications. Malyshev et al. first optimized conditions to increase the extracellular stability of synthetic nucleobases so that the half-lives of both d5SICS and dNaM were increased to ~9 hours. For successful replication, the unnatural nucleobases must be present inside the cell, so the authors then transformed Escherichia coli to contain an algal nucleotide triphosphate transporter (NTT2), which imports d5SICS and dNaM through the cell membrane. They also transformed the cells with an engineered plasmid (pINF) in which the dA∙dT base pair at position 505 was replaced with a base pair between dNaM and an analogue of d5SICS, so that later measurements of d5SICS would confirm the in vivo replication of the plasmid. After 15 hours of growth (~24 doublings) in medium containing the synthetic nucleobases, pINF was recovered from the cells and digested into nucleosides. To measure the level of UBP retention, the ratios of nucleosides (as identified from liquid chromatography–tandem mass spectrometry) were compared, which indicated the presence of ~1 UBP per plasmid.